Midday movers: Affirm, Amazon, and More
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St slips as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia releases AI safety software it says could have stopped Hugging Face hack
Amazon.com (AMZN) Mentioned Positively at Citi, Top Pick
November 29, 2023 7:57 AM ESTCiti analyst Ronald Josey reiterated a Buy rating and $177.00 price target on Amazon.com (NASDAQ: AMZN)
The analyst comments "Following our time at AWS and after hosting our 7th Annual Citi Cloud Forum with Citis Software Analysts Tyler Radke and Fatima Boolani, we... More
Amazon.com (AMZN) Mentioned Positively at Susquehanna
November 29, 2023 7:27 AM ESTSusquehanna analyst Shyam Patil reiterated a Positive rating and $185.00 price target on Amazon.com (NASDAQ: AMZN)
The analyst comments "Unveiling Amazon Q, an AI chatbot for enterprises. One of the key product announcements at this years re:Invent conference was a generative AI tool Amazon Q, a new AI-powered assistant designed for enterprises. The product, currently... More
Shopify (SHOP) holds an 'untenable valuation' - Piper Sandler
November 28, 2023 8:31 AM ESTShopify (NYSE: SHOP) shares were cut to Underweight from Neutral at Piper Sandler on Tuesday, with analyst Clarke Jeffries lowering the price target to $56 from $58 per share.
Jeffries said in a note that the firm decided to revisit its investment thesis... More
Teva Pharma 'uniquely positioned,' Jazz Pharmaceuticals set-up balanced - UBS
November 27, 2023 11:21 AM ESTInvestment bankUBS raised Teva Pharma (NYSE: TEVA) to Buy from Neutral and downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) to Neutral from Buy in separate notes to clients on Monday.
Analyst Ashwani Verma raised the TEVA price target to $13 from $11 per share, stating the brand transition is underway and launch... More
